Evidence map›Paper›PMID 28596487›Full record

ArticleOncotarget2017

ZNF131 suppresses centrosome fragmentation in glioblastoma stem-like cells through regulation of HAUS5.

Yu Ding, Jacob A Herman, Chad M Toledo, Jackie M Lang, Philip Corrin, Emily J Girard, Ryan Basom, Jeffrey J Delrow, James M Olson, Patrick J Paddison

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. NAR cancer · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. How Microtubules Build the Spindle Branch by Branch.Annual review of cell and developmental biology · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Establishment of a Genomic-Clinicopathologic Nomogram for Predicting Early Recurrence of Hepatocellular Carcinoma After R0 Resection.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Yu DingHuman Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Jacob A HermanHuman Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Chad M ToledoHuman Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Jackie M LangBasic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Philip CorrinHuman Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Emily J GirardClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Ryan BasomGenomics and Bioinformatics Shared Resources, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Jeffrey J DelrowGenomics and Bioinformatics Shared Resources, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
James M OlsonClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Patrick J PaddisonHuman Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Fred Hutch Cancer Center · USUniversity of Washington · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
Testing a cancer patient-specific SARS-CoV-2 vaccine in chemotherapy- and radiation-treated pediatric brain tumor mouse modelsR01CA114567 · NCI · SEATTLE CHILDREN'S HOSPITAL · PI OLSON, JAMES M · 2006 to 2023
$4.9M
MYC-dependent loss of splicing fidelity in Glioblastoma multiformeR01CA190957 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PADDISON, PATRICK · 2015 to 2019
$2.2M
Infant and Toddler Brain TumorsR01CA155360 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI OLSON, JAMES M · 2011 to 2015
$1.8M
Evolution of cancer-specific molecular requirements for glioblastoma multiforme (R21CA170722 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PADDISON, PATRICK, ZHU, JUN · 2012 to 2013
$418k
NCI NIH HHS P30 CA015704NCI NIH HHS R01 CA114567NCI NIH HHS R01 CA155360NCI NIH HHS R01 CA190957NCI NIH HHS R21 CA170722
6 · The paper itself

Abstract

Zinc finger domain genes comprise ~3% of the human genome, yet many of their functions remain unknown. Here we investigated roles for the vertebrate-specific BTB domain zinc finger gene ZNF131 in the context of human brain tumors. We report that ZNF131 is broadly required for Glioblastoma stem-like cell (GSC) viability, but dispensable for neural progenitor cell (NPC) viability. Examination of gene expression changes after ZNF131 knockdown (kd) revealed that ZNF131 activity notably promotes expression of Joubert Syndrome ciliopathy genes, including KIF7, NPHP1, and TMEM237, as well as HAUS5, a component of Augmin/HAUS complex that facilitates microtubule nucleation along the mitotic spindle. Of these genes only kd of HAUS5 displayed GSC-specific viability loss. Critically, HAUS5 ectopic expression was sufficient to suppress viability defects of ZNF131 kd cells. Moreover, ZNF131 and HAUS5 kd phenocopied each other in GSCs, each causing: mitotic arrest, centrosome fragmentation, loss of Augmin/HAUS complex on the mitotic spindle, and loss of GSC self-renewal and tumor formation capacity. In control NPCs, we observed centrosome fragmentation and lethality only when HAUS5 kd was combined with kd of HAUS2 or HAUS4, demonstrating that the complex is essential in NPCs, but that GSCs have heightened requirement. Our results suggest that GSCs differentially rely on ZNF131-dependent expression of HAUS5 as well as the Augmin/HAUS complex activity to maintain the integrity of centrosome function and viability.

Indexed as

Gene Expression Regulation, NeoplasticBrain NeoplasmsCell Cycle ProteinsCell Line, TumorCell Self RenewalCell Transformation, NeoplasticCentrosomeDNA-Binding ProteinsGene Knockdown TechniquesGlioblastomaHumansMicrotubule-Associated ProteinsMicrotubulesNeoplastic Stem CellsProtein BindingSpindle Apparatusaugmin protein, humanCell Cycle ProteinsDNA-Binding ProteinsMicrotubule-Associated ProteinsTranscription FactorsZNF131 protein, humanAugmin/HAUS complexcancer therapeuticsglioblastomaHAUS5ZNF131

Identifiers

PMID28596487
PMCPMC5564707
OpenAlexW2618156182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.